Targeting Epac2 and GluA3-containing AMPARs: a novel therapeutic strategy for Alzheimer’s disease
Saved in:
| Main Authors: | Tong Zhang, Martina Schmidt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-11-01
|
| Series: | Neural Regeneration Research |
| Online Access: | https://journals.lww.com/10.4103/NRR.NRR-D-24-00751 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GluA2 palmitoylation by SELENOK modulates AMPAR assembly and synaptic plasticity in Alzheimer's disease
by: Jiaying Peng, et al.
Published: (2025-10-01) -
Identification of a novel signaling pathway and its relevance for GluA1 recycling.
by: Guiscard Seebohm, et al.
Published: (2012-01-01) -
Cysteine 893 is a target of regulatory thiol modifications of GluA1 AMPA receptors.
by: Lotta von Ossowski, et al.
Published: (2017-01-01) -
AMPA GluA1-flip targeted oligonucleotide therapy reduces neonatal seizures and hyperexcitability.
by: Nicole M Lykens, et al.
Published: (2017-01-01) -
GluA1 Phosphorylation Alters Evoked Firing Pattern In Vivo
by: Balázs Barkóczi, et al.
Published: (2012-01-01)